Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Language
Publication year range
1.
Braz J Med Biol Res ; 51(9): e7552, 2018 Jul 02.
Article in English | MEDLINE | ID: mdl-29972429

ABSTRACT

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.


Subject(s)
Antioxidants/pharmacology , Caenorhabditis elegans/drug effects , Paullinia/chemistry , Plant Extracts/pharmacology , Aging/drug effects , Animals , Antioxidants/isolation & purification , Caenorhabditis elegans/physiology , Longevity/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Time Factors
2.
Braz. j. med. biol. res ; 51(9): e7552, 2018. tab, graf
Article in English | LILACS | ID: biblio-951753

ABSTRACT

Guarana (Paullinia cupana) is habitually ingested by people in the Amazon region and is a key ingredient in various energy drinks consumed worldwide. Extension in longevity and low prevalence of chronic age-related diseases have been associated to habitual intake of guarana. Anti-aging potential of guarana was also demonstrated in Caenorhabditis elegans; however, the mechanisms involved in its effects are not clear. Herein, we investigated the putative pathways that regulate the effects of guarana ethanolic extract (GEE) on lifespan using C. elegans. The major known longevity pathways were analyzed through mutant worms and RT-qPCR assay (DAF-2, DAF-16, SKN-1, SIR-2.1, HSF-1). The possible involvement of purinergic signaling was also investigated. This study demonstrated that GEE acts through antioxidant activity, DAF-16, HSF-1, and SKN-1 pathways, and human adenosine receptor ortholog (ADOR-1) to extend lifespan. GEE also downregulated skn-1, daf-16, sir-2.1 and hsp-16.2 in 9-day-old C. elegans, which might reflect less need to activate these protective genes due to direct antioxidant effects. Our results contribute to the comprehension of guarana effects in vivo, which might be helpful to prevent or treat aging-associated disorders, and also suggest purinergic signaling as a plausible therapeutic target for longevity studies.


Subject(s)
Animals , Plant Extracts/pharmacology , Caenorhabditis elegans/drug effects , Paullinia/chemistry , Antioxidants/pharmacology , Time Factors , Aging/drug effects , Caenorhabditis elegans/physiology , Reverse Transcriptase Polymerase Chain Reaction , Longevity/drug effects , Antioxidants/isolation & purification
3.
Braz J Med Biol Res ; 49(9): e5235, 2016 Aug 01.
Article in English | MEDLINE | ID: mdl-27533765

ABSTRACT

Improving overall health and quality of life, preventing diseases and increasing life expectancy are key concerns in the field of public health. The search for antioxidants that can inhibit oxidative damage in cells has received a lot of attention. Rosmarinus officinalis L. represents an exceptionally rich source of bioactive compounds with pharmacological properties. In the present study, we explored the effects of the ethanolic extract of R. officinalis (eeRo) on stress resistance and longevity using the non-parasitic nematode Caenorhabditis elegans as a model. We report for the first time that eeRo increased resistance against oxidative and thermal stress and extended C. elegans longevity in an insulin/IGF signaling pathway-dependent manner. These data emphasize the eeRo beneficial effects on C. elegans under stress.


Subject(s)
Caenorhabditis elegans/drug effects , Longevity/drug effects , Oxidative Stress/drug effects , Rosmarinus/chemistry , Stress, Physiological/drug effects , Animals , Caenorhabditis elegans Proteins/drug effects , DNA-Binding Proteins/drug effects , Forkhead Transcription Factors/drug effects , Signal Transduction/drug effects , Transcription Factors/drug effects
4.
Braz. j. med. biol. res ; 49(9): e5235, 2016. tab, graf
Article in English | LILACS | ID: lil-788945

ABSTRACT

Improving overall health and quality of life, preventing diseases and increasing life expectancy are key concerns in the field of public health. The search for antioxidants that can inhibit oxidative damage in cells has received a lot of attention. Rosmarinus officinalis L. represents an exceptionally rich source of bioactive compounds with pharmacological properties. In the present study, we explored the effects of the ethanolic extract of R. officinalis (eeRo) on stress resistance and longevity using the non-parasitic nematode Caenorhabditis elegans as a model. We report for the first time that eeRo increased resistance against oxidative and thermal stress and extended C. elegans longevity in an insulin/IGF signaling pathway-dependent manner. These data emphasize the eeRo beneficial effects on C. elegans under stress.


Subject(s)
Animals , Caenorhabditis elegans/drug effects , Longevity/drug effects , Oxidative Stress/drug effects , Rosmarinus/chemistry , Stress, Physiological/drug effects , Caenorhabditis elegans Proteins/drug effects , DNA-Binding Proteins/drug effects , Forkhead Transcription Factors/drug effects , Signal Transduction/drug effects , Transcription Factors/drug effects
5.
Neuroscience ; 278: 40-50, 2014 Oct 10.
Article in English | MEDLINE | ID: mdl-25130558

ABSTRACT

Alzheimer's disease (AD) is the most common and devastating neurodegenerative disease. The etiology of AD has yet to be fully understood, and common treatments remain largely non-efficacious. The amyloid hypothesis posits that extracellular amyloid-ß (Aß) deposits are the fundamental etiological factor of the disease. The present study tested the organoselenium compound diphenyl-diselenide (PhSe)2, which is characterized by its antioxidant and antiinflammatory properties and has shown efficacy in several neurodegenerative disease models. We employed a transgenic Caenorhabditis elegans AD model to analyze the effects of (PhSe)2 treatment on Aß peptide-induced toxicity. Chronic exposure to (PhSe)2 attenuated oxidative stress induced by Aß1-42, with concomitant recovery of associative learning memory in C. elegans. Additionally, (PhSe)2 decreased Aß1-42 transgene expression, suppressed Aß1-42 peptide, and downregulated hsp-16.2 by reducing the need for this chaperone under Aß1-42-induced toxicity. These observations suggest that (PhSe)2 plays an important role in protecting against oxidative stress-induced toxicity, thus representing a promising pharmaceutical modality that attenuates Aß1-42 expression.


Subject(s)
Alzheimer Disease/drug therapy , Alzheimer Disease/metabolism , Amyloid beta-Peptides/antagonists & inhibitors , Antioxidants/administration & dosage , Organoselenium Compounds/administration & dosage , Peptide Fragments/antagonists & inhibitors , Aldicarb/pharmacology , Alzheimer Disease/psychology , Amyloid beta-Peptides/metabolism , Animals , Animals, Genetically Modified , Association Learning/drug effects , Caenorhabditis elegans , Caenorhabditis elegans Proteins/metabolism , Cholinesterase Inhibitors/pharmacology , Disease Models, Animal , Heat-Shock Proteins/metabolism , Motor Activity/drug effects , Oxidative Stress/drug effects , Peptide Fragments/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...